Page 11234..1020..»

Category Archives: ALS Treatment

Genetic Therapy Shows Promise for ALS and Dementia in Animal Models – Technology Networks

Posted: Published on February 20th, 2024

Macquarie University neuroscientists have developed a single-dose genetic medicine that has been proven to halt the progression of both motor neurone disease (MND) and frontotemporal dementia (FTD) in mice and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunities for treating more common forms of dementia, such as Alzheimers disease, which is the second most common cause of death in Australia after heart disease. The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord. Continue reading

Posted in ALS Treatment | Comments Off on Genetic Therapy Shows Promise for ALS and Dementia in Animal Models – Technology Networks

Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice – News-Medical.Net

Posted: Published on February 20th, 2024

Neuroscientists at Macquarie University in Australia have developed a single-dose genetic medicine that has been proven to halt the progression of both ALS and frontotemporal dementia (FTD) in mice and may even offer the potential to reverse some of the effects of the fatal diseases. It may also hold opportunities for treating more common forms of dementia, such as Alzheimer's disease. The new treatment, dubbed CTx1000, targets pathological build-ups of the protein TDP-43 in cells in the brain and spinal cord, which has been It has been associated with ALS, FTD and other forms of dementia Continue reading

Posted in ALS Treatment | Comments Off on Single-dose genetic medicine halts the progression of ALS and frontotemporal dementia in mice – News-Medical.Net

Steve ‘Mongo’ McMichael update: Chicago Bears Hall of Famer being treated for MRSA infection UTI, in ICU amid ALS battle – WLS-TV

Posted: Published on February 20th, 2024

The page you requested was not found. You may have followed an old link or typed the address incorrectly. We've also been doing some house cleaning so the page may have been moved or removed. Continue reading

Posted in ALS Treatment | Comments Off on Steve ‘Mongo’ McMichael update: Chicago Bears Hall of Famer being treated for MRSA infection UTI, in ICU amid ALS battle – WLS-TV

Significant Setback in ALS Treatment Development: What’s Next for Neurological Disease Treatments? – Medriva

Posted: Published on February 20th, 2024

A Significant Setback in ALS Treatment Development Denali Therapeutics and Sanofi, two notable names in the pharmaceutical industry, recently suffered a significant setback in their attempt to develop a promising treatment for Amyotrophic Lateral Sclerosis (ALS). The drug, which was in a mid-stage trial, did not meet its primary objective, casting a shadow over the future prospects of this potential treatment option. ALS is a progressive neurological disease that affects nerve cells in the brain and spinal cord, leading to muscle weakness and severe physical disability. Continue reading

Posted in ALS Treatment | Comments Off on Significant Setback in ALS Treatment Development: What’s Next for Neurological Disease Treatments? – Medriva

Cellenkos Approved to Proceed with CK0803 Neurotrophic T regulatory Cell therapy to Treat Second Cohort in ALS Trial – PR Newswire

Posted: Published on February 20th, 2024

HOUSTON, Feb. Continue reading

Posted in ALS Treatment | Comments Off on Cellenkos Approved to Proceed with CK0803 Neurotrophic T regulatory Cell therapy to Treat Second Cohort in ALS Trial – PR Newswire

Amylyx to present ALS treatment developments at MDA conference By Investing.com – Investing.com

Posted: Published on February 20th, 2024

CAMBRIDGE, Mass. - Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has announced that it will present new research on two of its investigational treatments for amyotrophic lateral sclerosis (ALS) at the upcoming Muscular Dystrophy Association (MDA) Clinical and Scientific Conference in Orlando, Florida. Continue reading

Posted in ALS Treatment | Comments Off on Amylyx to present ALS treatment developments at MDA conference By Investing.com – Investing.com

Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva

Posted: Published on February 12th, 2024

A Breakthrough in ALS Treatment Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease characterized by rapid, progressive loss of motor neurons in the brain and spinal cord. This debilitating condition, for which there is currently no cure, may soon see a ray of hope with the discovery of a new pharmacological inhibitor, FP802. Recent research funded by the German Research Foundation, the European Research Council, and the Alexander von Humboldt Foundation has unveiled the potential of this inhibitor in the treatment of ALS. Continue reading

Posted in ALS Treatment | Comments Off on Breakthrough in ALS Treatment: FP802 Inhibitor Shows Promise – Medriva

New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net

Posted: Published on February 12th, 2024

A new pharmacological inhibitor can intervene in a central cell death mechanism that is responsible for the death of motor neurons and hence important for the progression of the motor neuron disease amyotrophic lateral sclerosis (ALS). A research team led by Prof Continue reading

Posted in ALS Treatment | Comments Off on New drug targets key mechanism in ALS, protects motor neurons – News-Medical.Net

Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva

Posted: Published on February 12th, 2024

Groundbreaking Discovery by Heidelberg University In a major advancement towards the treatment of amyotrophic lateral sclerosis (ALS), a research team led by Prof. Dr. Continue reading

Posted in ALS Treatment | Comments Off on Heidelberg University’s Groundbreaking Discovery in ALS Treatment – Medriva

Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva

Posted: Published on February 12th, 2024

Amyotrophic lateral sclerosis (ALS), also known as Lou Gehrigs disease, is a progressive neurodegenerative condition marked by the loss of motor neurons, cells that control voluntary muscles. This fatal disease has been a longstanding challenge for researchers and physicians, with no effective cure available Continue reading

Posted in ALS Treatment | Comments Off on Revolutionary Discovery: FP802 Inhibitor Offers Hope for ALS Patients – Medriva

Page 11234..1020..»